Grace Therapeutics Inc.

GRCE | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.13

+$0.03 (+1.43%)

Sep 22, 2026, 2:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $34.18M

Enterprise Value $20.42M

Beta 0.37

Average Volume 271.38K

Shares Outstanding (Diluted) 17.27M

Shares Change YoY 8.45%

Institutional Ownership 25.83%

Exchange NASDAQ

ISIN US00439U1043

Price Performance

Price Change 1M -5.8%

Price Change 3M -12.1%

Price Change 6M -55.2%

Price Change YTD -42.6%

Price Change 1Y -32.5%

Price Change 3Y -32.5%

Price Change 5Y -32.5%

1M CAGR (ann.) -1.4%

1Y CAGR (ann.) -32.7%

5Y CAGR (ann.) N/A

All-Time CAGR -16.7%

Valuation

PE Ratio -1.67

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.05

PS Ratio N/A

Forward PS 6.80

PB Ratio 0.71

P/FCF Ratio -3.32

P/Adj. FCF Ratio -3.20

P/OCF Ratio -3.50

EV/Sales N/A

EV/EBIT -0.79

EV/EBITDA -0.80

EV/FCF -1.98

Earnings Yield -60.0%

FCF Yield -30.1%

Adj. FCF Yield -31.3%

Financial Health

Net Cash $13.76M

Total Debt $0

Cash & Short-Term Investments $13.76M

Total Assets $50.07M

Current Ratio 11.47

Quick Ratio 11.47

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 2.80

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -3.8%

Returns

Return on Assets -42.8%

Return on Equity -35.8%

Return on Invested Capital -48.8%

Return on Capital Employed -52.6%

Return on Tangible Assets -149.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -6.1%

EPS CAGR 3Y 14.0%

EPS CAGR 5Y 29.4%

EPS CAGR 10Y 31.2%

FCF CAGR 3Y -2.7%

FCF CAGR 5Y 15.6%

FCF CAGR 10Y 2.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y 75.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.15

EPS Growth Est (next Q) 82.5%

Revenue Est (next Q) $1M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $4

Price Target Upside 90.5%

Cash Flow

Operating Cash Flow $-10.3M

Free Cash Flow $-10.3M

Adj. Free Cash Flow $-10.7M

FCF Per Share -$0.60

OCF Per Share -$0.60

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-2K

Operating Income $-25.69M

EBITDA $-25.68M

Net Income $-21.45M

EPS (Diluted) -$1.26

Revenue / Employee N/A

Profit / Employee $-4.29M

Employees 5